# Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate Cancer

> **NCT01731912** · NA · COMPLETED · sponsor: **University of Washington** · enrollment: 16 (actual)

## Conditions studied

- Prostate Adenocarcinoma
- Stage IIA Prostate Cancer
- Stage IIB Prostate Cancer
- Stage III Prostate Cancer
- Stage IV Prostate Cancer

## Interventions

- **DRUG:** Degarelix
- **RADIATION:** External Beam Radiation Therapy
- **OTHER:** Laboratory Biomarker Analysis

## Key facts

- **NCT ID:** NCT01731912
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01731912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01731912, "Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate Cancer". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT01731912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*